Skip to main content
  • Saved

made a Post

IL-31 induces antitumor immunity in breast carcinoma

IL-31 induces antitumor immunity in breast carcinoma

Source :

https://jitc.bmj.com/content/8/2/e001010?rss=1

Background Immunomodulatory agents that induce antitumor immunity have great potential for treatment of cancer. We have previously shown that interleukin (IL)-31, a proinflammatory cytokine from the IL-6 family, acts as an antiangiogenic agent. Here, we characterize the immunomodulatory effect of IL-31 in breast cancer.